Fierce Biotech February 27, 2024
Less than three years after debuting on the New York Stock Exchange in an initial public offering, Agiliti is leaving the public market.
The medical equipment management company has entered into a take-private deal with its majority shareholder, Thomas H. Lee Partners, or THL, according to a Monday announcement.
Agiliti’s board of directors has approved the transaction—based on the unanimous recommendation of a designated special committee within the board—as has THL. It’s expected to close sometime within the first half of this year.
Under the terms of the deal, the private equity firm will pay out $10 for each share of Agiliti’s stock not already owned by THL or “certain management shareholders.” According to the release, that represents a premium...
Today's Sponsors
Today's Sponsor